# SynchroMed II Post-Approval Study

> **NCT00773019** · — · COMPLETED · sponsor: **MedtronicNeuro** · enrollment: 84 (actual)

## Conditions studied

- Severe Spasticity
- Chronic Pain

## Interventions

- **DEVICE:** Refills (SynchroMed® II Programmable Drug Infusion Pump)

## Key facts

- **NCT ID:** NCT00773019
- **Lead sponsor:** MedtronicNeuro
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-11
- **Primary completion:** 2008-06
- **Final completion:** 2008-11
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2023-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00773019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00773019, "SynchroMed II Post-Approval Study". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00773019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*